So we want to explore the relationship between oxaliplatin (the most commonly used chemotherapeutic drug) and NLRP3 level and the role of NLRP3 in of oxaliplatin sensitivity in HCC. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.